Abstract-A high-sensitivity, fully-passive neurosensing system is presented for wireless brain signal monitoring. The proposed system is able to detect very low power brain-like signals, viz. as low as -82 dBm (50 μVpp) at fneuro > 1 kHz. It is also able to read emulated neural signals as low as -70 dBm (200 μVpp) at fneuro > 100 Hz. This is an improvement of up to 22 dB in sensitivity as compared to previously reported neural signals. The system is comprised of an implanted neurosensor and an exterior interrogator. The neurosensor receives an external carrier signal and mixes it with the neural signals prior to retransmitting to the interrogator. Of importance is that the implanted neurosensor is fully passive and does not require a battery nor rectifier/regulator, but is concurrently wireless for unobtrusive neurosensing with minimal impact to the individual's activity. To achieve this remarkable high sensitivity, the sensing system employed: (a) a sub-harmonic mixer using an anti-parallel diode pair (APDP), (b) a pair of implanted/interrogator antennas with high transmission coefficient, |S21|, and (c) a matching circuit between the implanted antenna and the mixer. This neurosensing system brings forward a new possibility of wireless neural signal detection using passive brain implants.Index Terms-Anti-parallel diode pair (APDP), brain implant, neurosensing, passive, wireless medical telemetry, sub-harmonic mixing.
The proposed recorder brings forward transformational possibilities in wireless fully passive neural detection for a very wide range of applications (e.g., epilepsy, Alzheimer's, mental disorders, etc.).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.